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The protein kinase KSR interacts with 14-3-3 protein and Raf
Heming Xing*†, Kerry Kornfeld‡ and Anthony J. Muslin*†
Background: KSR (kinase suppressor of Ras) is a recently identified putative
protein kinase that positively mediates the Ras signaling pathway in the
invertebrates Caenorhabditis elegans and Drosophila melanogaster. The
function of vertebrate KSR is not well characterized biochemically or biologically.
Results: We examined the physiological role of KSR in vertebrate signal
transduction using Xenopus laevis oocytes. Overexpression of KSR, in
combination with overexpression of the intracellular dimeric protein 14-3-3,
induced Xenopus oocyte meiotic maturation and cdc2 kinase activation; the
effect of KSR and 14-3-3 on oocyte maturation was blocked by co-expression of
dominant-negative Raf-1. We noted that KSR contains multiple potential binding
sites for 14-3-3, and we used the yeast two-hybrid system and co-
immunoprecipitation experiments to show that KSR can bind to 14-3-3.
Furthermore, we demonstrated that KSR can form a complex with Raf kinase
both in vitro and in cultured cells. Cell fractionation studies revealed that KSR
formed a complex with 14-3-3 in both the membrane and cytoplasmic fractions
of cell lysates; however, KSR only formed a complex with Raf-1 in the membrane
fraction. 
Conclusions: Our findings suggest that KSR, 14-3-3 and Raf form an oligomeric
signaling complex and that KSR positively regulates the Ras signaling pathway in
vertebrate organisms.
Background
The Ras signaling pathway plays a critical role in the regu-
lation of cell differentiation, movement and proliferation
[1]. Activated, GTP-bound Ras binds to Raf, and this
interaction promotes Raf activation. Some evidence sug-
gests that a critical function of Ras is to localize Raf to the
plasma membrane where Raf may be post-translationally
modified and activated [2,3]. Although the activation of
Raf is known to be critical for Ras-mediated signaling, the
proteins that function in conjunction with Ras to activate
Raf have not been definitively identified. The activation
of Raf in vivo may require its phosphorylation at various
serine, threonine and tyrosine residues; there is some evi-
dence for the involvement of each of several specific Raf
residues: Ser259, Ser499, Ser621, Thr269, Tyr340 and
Tyr341 [4–8]. However, the relative contribution to Raf
activation in vivo of phosphorylation at each of these
residues has not been clearly established.
Raf appears to be part of a high molecular weight complex
within cells [9], and this complex is likely to include
members of two groups of proteins that are constitutively
bound to Raf in many cell types: heat shock proteins and
14-3-3 proteins [9–14]. Raf activation appears to be poten-
tiated by members of the 14-3-3 protein family — a highly
conserved group of dimeric proteins known generically as
14-3-3 [10–14]. Although the mechanism of action of
14-3-3 is poorly understood, some evidence suggests that
binding to 14-3-3 protects Raf from dephosphorylation
[4,15]. Alternatively, 14-3-3 may function either as a
linker, by assembling Raf and other signaling proteins into
a complex [16], or as a chaperone, by stabilizing Raf in a
conformation which is accessible for activation [15].
Several important signaling proteins in cells interact with
14-3-3 [11], which binds to proteins containing the serine-
phosphorylated motif Arg–Ser–X–pSer–X–Pro (in which X
is any amino acid and pSer is phosphoserine) [15]; 14-3-3
may also bind to proteins that contain cysteine-rich zinc-
finger domains [6]. 
The KSR (kinase suppressor of Ras) family of proteins was
recently discovered and shown to be involved in Ras sig-
naling [17–19]. Genetic analyses of the Caenorhabditis
elegans ksr-1 gene and the Drosophila melanogaster ksr gene
suggest that the products of these genes positively mediate
Ras signaling and function downstream of, or parallel to,
Ras [17–19]. Genes homologous to the invertebrate ksr
genes have been identified in mice and humans, but the
function of these genes is not well defined [19]. The pro-
teins predicted to be encoded by the ksr genes contain a
highly conserved protein kinase domain, a cysteine-rich
zinc-finger-like domain, and two amino-acid sequences
related to the 14-3-3-binding motif Arg–Ser–X–Ser–X–Pro
[15]. KSR proteins appear to define a distinct group of
protein kinases, which most closely resemble members of
the Raf family.
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In order to determine the role of KSR in vertebrate signal
transduction, we examined the ability of KSR to potenti-
ate meiotic maturation in Xenopus laevis oocytes — a
process which is believed to be mediated by the Ras sig-
naling pathway, involving the activation of Mitogen-acti-
vated protein (MAP) kinase and culminating in germinal
vesicle breakdown (GVBD) and the activation of meiotic
maturation markers such as cdc2 kinase activity [20]. We
also investigated whether KSR can bind to 14-3-3 and Raf.
Our results suggest that KSR potentiates the stimulation
of Raf-mediated signaling by 14-3-3, and that KSR is able
to form a complex with both Raf and 14-3-3.
Results
KSR cooperates with 14-3-3 to promote Xenopus oocyte
maturation
Genetic epistatic analysis in Drosophila suggests that ksr
functions upstream of Raf to positively mediate Ras sig-
naling [19]. Although homologous vertebrate ksr genes
have been cloned on the basis of sequence similarity [19],
the function of vertebrate KSR proteins in signal transduc-
tion is not well defined. We first tested the ability of
murine KSR (muKSR) to activate the Ras signaling
pathway using a well-defined bioassay — meiotic matura-
tion of Xenopus oocytes [20]. The muKSR cDNA was used
to generate RNA by transcription in vitro; RNA was
injected into immature oocytes and GVBD and cdc2
kinase activity were assessed. Injection of 10–20 pg
muKSR RNA per oocyte did not induce significantly more
GVBD or activation of cdc2 kinase than did injection of
water as a control (Fig. 1a,c). Injection of muKSR RNA
resulted in GVBD in 9–12% of oocytes compared to 6–8%
for control oocytes (Fig. 1a); doubling the dosage of
muKSR RNA did not increase the fraction of oocytes that
displayed GVBD (data not shown).
We next tested the ability of KSR to promote maturation
in oocytes that were stimulated by expression of one form
of human 14-3-3, 14-3-3 z. Injection of 10–20 pg of
14-3-3 z RNA per oocyte induced GVBD in 18–21% of
oocytes (Fig. 1a), consistent with previously reported
results [12]. Co-injection of 14-3-3 z and muKSR RNAs
(20–40 pg RNA in total) resulted in GVBD in 42–50% of
oocytes, as determined in eight independent experiments
(Fig. 1a), as well as a marked increase in the rate at which
GVBD was detected (data not shown). In addition to an
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(a) KSR stimulates Xenopus oocyte maturation when co-expressed
with 14-3-3. Immature Xenopus oocytes were injected with RNAs
encoding muKSR (KSR), human 14-3-3 z (14), and dominant negative
Raf (NAF) in various combinations. Groups of 40–50 oocytes were
scored for GVBD after 24 h by assessing the appearance of a broad
white spot at the animal pole of the oocyte. Two representative sets of
data (out of 8) are shown. As a control, water (H2O) was injected
instead of RNA. (b) Wild-type Raf antagonizes the effect of NAF on
KSR-induced oocyte maturation. Immature Xenopus laevis oocytes
were injected with RNAs encoding muKSR (KSR), human 14-3-3 z
(14), wild type Raf (RAF), and dominant negative Raf (NAF) in various
combinations. Some oocytes were stimulated with 8.25 mg ml–1
insulin. Groups of 40–50 oocytes were scored for GVBD after 24 h.
One representative set of data (out of 3) is shown. As a control, water
(H2O) was injected instead of RNA. (c) Cdc2 kinase is activated by
14-3-3 and KSR in oocytes. Using p13suc beads, cdc2 kinase was
purified from Xenopus oocytes that had been injected with the various
combinations of RNAs used in (a). Histone H1 was added to
immobilized cdc2 in the presence of [32P]ATP, and the radiolabeled
proteins were analyzed by SDS–PAGE followed by autoradiography.
These data are representative of three separate experiments. (d) MAP
kinase is activated by 14-3-3 and KSR in oocytes. MAP kinase was
purified from injected Xenopus oocytes, labeled as in (a), using
agarose-conjugated anti-MAP-kinase antisera. Myelin basic protein
was added to immobilized MAP kinase in the presence of [32P]ATP,
radiolabeled proteins were separated by SDS–PAGE, and the bands
corresponding to myelin basic protein were isolated and analyzed by
scintigraphy. Each column is the average of two experiments. Data are
expressed as the fold induction of MAP kinase activity over control (the
activity from water-injected oocytes).
increase in GVBD, co-injected oocytes displayed a signifi-
cant increase in cdc2 kinase activity (Fig. 1c) and MAP
kinase activity (Fig. 1d). 
A dominant negative form of Raf (NAF) that contains a
point mutation at the ATP binding site (Lys375→Met)
was also used for oocyte injection experiments; co-injec-
tion of three RNAs — 14-3-3 z, muKSR and NAF
(30–60 pg RNA in total) — reduced GVBD, cdc2 kinase
activity, and MAP kinase activity to basal levels (Fig.
1a,c,d). Insulin treatment of oocytes results in Ras and Raf
activation and leads to oocyte maturation [21,22]. Treat-
ment of oocytes injected with 14-3-3 z, muKSR and NAF
RNAs with insulin did not potentiate GVBD; however,
co-injection of a fourth RNA, wild-type Raf RNA,
(40–80 pg RNA in total) resulted in marked induction of
GVBD (Fig. 1b), suggesting that the effect of NAF was
specific to Raf. Taken together, these results demonstrate
that KSR and 14-3-3 cooperate to promote GVBD in a
Raf-dependent manner.
Subcellular localization of KSR
The results of the oocyte injection experiments suggested
that muKSR plays a physiological role in the activation of
the Ras signaling pathway in vertebrate cells. In order to
investigate the mechanism of action of KSR in signal
transduction, we examined the subcellular localization of
KSR and the ability of KSR to interact with other proteins.
To characterize KSR biochemically, we first generated a
monoclonal antibody against an amino-terminal peptide of
muKSR (Cys–Thr–Gln–Gln–Glu–Ile–Arg–Thr–Leu–Glu
–Ala–Lys–Leu–Val–Lys). This antibody specifically rec-
ognized a band of approximately 105 kDa on western blots
of murine fibroblast lysates and Xenopus oocyte lysates
(Fig. 2a and data not shown), and this band was not visual-
ized when antigenic peptide was added with the mono-
clonal antibody (data not shown). On some immunoblots,
a doublet was noted at 105–108 kDa (data not shown). A
commercial polyclonal anti-KSR antibody (Santa Cruz
Biotech) raised against a different antigenic peptide also
specifically recognized a band of 105 kDa (Fig. 2a). These
results suggest that KSR migrates as a 105 kDa protein
and that KSR is specifically recognized by these antibody
preparations. 
The intracellular localization of murine KSR was investi-
gated using subcellular fractionation experiments. Murine
fibroblasts were lysed in detergent-free buffer, and the
lysates were separated by high-speed centrifugation into
supernatant (S100) and pellet (P100) fractions and ana-
lyzed by immunoblotting using an anti-KSR polyclonal
antibody: previous work had shown that cytoplasmic pro-
teins are primarily found in the S100 fraction, whereas
membrane-associated proteins are primarily localized in
the P100 fraction [2,3]. Figure 2b demonstrates that
although KSR was found primarily in the cytoplasmic
(S100) fraction of serum-starved cells, it was found primar-
ily in the membrane (P100) fraction of cells that had been
stimulated with serum for 10 minutes. On some
immunoblots, KSR in the membrane (P100) fraction dis-
played retarded mobility, consistent with a post-transla-
tional modification such as phosphorylation (data not
shown). Using the same fractionation assay, previous work
has demonstrated that the small GTP-binding protein
rhoA translocates from the cytoplasm to the membrane at
reproducible time points following serum-stimulation of
cells [23]. Parallel experiments examining the subcellular
localization of rhoA and KSR revealed that maximal levels
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Figure 2
(a) Immunoblot of murine fibroblast protein
lysates using anti-KSR antisera. Lysates from
subconfluent NIH 3T3 cells were separated
by SDS–PAGE and analyzed by
immunoblotting using a murine monoclonal
anti-KSR antibody (lane 1), a goat polyclonal
anti-KSR antibody (lane 2), or rabbit pre-
immune serum (lane 3). The migration of
protein size markers and bands likely to
correspond to KSR are indicated. A second
goat polyclonal anti-KSR antibody (Santa
Cruz Biotech) also bound to a 105 kDa band
(data not shown). (b) Subcellular localization
of KSR. Quiescent NIH 3T3 cells (cells
incubated for 24 h in medium containing 0.1%
fetal calf serum; labeled ‘–’) and serum-
stimulated NIH 3T3 cells (quiescent cells
stimulated with medium containing 10% fetal
calf serum for 10 min; labeled ‘+’) were lysed
in detergent-free lysis buffer and separated by
high-speed centrifugation. Cytosolic (S100)
and membrane (P100) fractions were
analyzed by immunoblotting using a goat
polyclonal anti-KSR antibody. Bands
corresponding to KSR were quantified by
densitometry using NIH Image. Each column
is the mean densitometric analysis of three
independent experiments (± SEM).
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of both proteins were found in the membrane (P100)
fraction after 10 minutes of serum stimulation (data not
shown).
KSR binds to 14-3-3 in yeast and vertebrate cells
We next investigated the possibility that invertebrate and
vertebrate forms of KSR bind to 14-3-3. The predicted C.
elegans KSR protein (ceKSR) contains two amino-acid motifs
related to the 14-3-3 binding motif Arg–Ser–X–Ser–X–Pro
(Arg–Thr–Ser–Ser–Gly–Ser, amino acids 153–158, and
Arg–Ser–Pro–Ser–Phe–Pro, amino acids 755–760) [17,18],
and also contains a cysteine-rich CR-1 domain — a similar
domain in Raf may be able to bind to 14-3-3 [6]. We exam-
ined the ability of ceKSR to interact with human 14-3-3 z
using the yeast two-hybrid system. Full-length ceKSR
interacted with 14-3-3 z but not with lamin, a generic
control protein (Table 1). Like ceKSR, muKSR contains a
CR-1 domain and two amino-acid motifs that are related
to the 14-3-3 binding motif (Arg–Thr–Glu–Ser–Val–Pro,
amino acids 389–394 and Arg–Arg–Leu–Ser–His–Pro,
amino acids 825–840) [3], and two-hybrid analysis in yeast
revealed that 14-3-3 z interacted with full-length muKSR
but not with lamin (Table 1).
In order to determine whether KSR and 14-3-3 interact in
vertebrate cells, co-immunoprecipitation experiments
were performed using murine fibroblasts. Subconfluent
NIH 3T3 cells were lysed, and muKSR immunoprecipi-
tates were analyzed by immunoblotting using an anti-
14-3-3 polyclonal antibody. This analysis revealed that
14-3-3 and muKSR formed a complex in vivo (Fig. 3a). To
analyze the subcellular localization of the KSR/14-3-3
complex, we fractionated extracts from fibroblasts and
separately analyzed the cytosolic (S100) and membrane
(P100) fractions; anti-KSR immunoprecipitates of each
fraction were analyzed by anti-14-3-3 immunoblotting,
revealing that KSR and 14-3-3 formed a complex in both
the cytoplasmic and membrane fractions of cultured
fibroblasts (Fig. 3b).
KSR binds to Raf in vitro and in vivo
Many protein kinases are activated by homodimerization
or heterodimerization: for example, the transforming
growth factor-b (TGF-b) receptor family of serine/threo-
nine kinases are activated by heterodimerization of Type I
and Type II receptors [24]. Recent work suggests that Raf
can also be activated by dimerization in cells [25,26].
Given that KSR is homologous to Raf, we investigated the
possibility that KSR can bind to Raf. 
A fusion protein of glutathione S-transferase (GST) and Raf
was produced in bacteria and used to determine if KSR
interacts with Raf in vitro. KSR derived from NIH 3T3 cells
bound to immobilized GST–Raf but not to GST protein
alone (Fig. 4a). The ability of KSR to associate with Raf in
vivo was tested by co-immunoprecipitation experiments;
protein lysates derived from subconfluent NIH 3T3 cells
were immunoprecipitated with anti-KSR. A western blot
revealed that the immunoprecipitate contained Raf, sug-
gesting that KSR and Raf form a complex in vivo (Fig. 4b).
We recently demonstrated that serine-phosphorylated pep-
tides based on sequences derived from Raf could disrupt
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Table 1
Detection of interactions between KSR and 14-3-3 proteins by
two-hybrid screening.
Transactivation domain fusion
Binding domain fusion 14-3-3 ceKSR
14-3-3 + +
muKSR + –
lamin – –
Yeast strain Y190 was co-transfected with plasmids encoding full-
length muKSR or ceKSR and human 14-3-3 z (14-3-3), and grown in
the absence of leucine and tryptophan. The efficacy of interactions
was determined qualitatively by Xgal staining; lamin was used as a
negative control.
Figure 3
(a) Co-immunoprecipitation of muKSR and
14-3-3 from NIH 3T3 cells. Protein samples
were analyzed by immunoblotting using an
anti-pan-14-3-3 antibody. The samples were
an extract of NIH 3T3 cells (3T3 lys), an
immunoprecipitate obtained using a polyclonal
anti-KSR antisera (KSR IP), and an
immunoprecipitate obtained using a rabbit
polyclonal anti-IgG antisera (control IP). The
arrow indicates the band that corresponds to
14-3-3. (b) KSR/14-3-3 complex formation in
membrane and cytosolic fractions. Quiescent
(–) and serum-stimulated (+) NIH 3T3 cells
were lysed in detergent-free buffer, and the
extracts were separated by high-speed
centrifugation to obtain cytosolic (S100) and
membrane (P100) fractions.
Immunoprecipitates obtained using a rabbit
polyclonal anti-IgG antisera (control IP) and
immunoprecipitates obtained using a
polyclonal anti-KSR antibody (KSR IP) were
analyzed using a polyclonal anti-14-3-3
antisera.
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complexes containing 14-3-3 [15]. In order to determine
whether the interaction of Raf with KSR was mediated by
14-3-3, 100 mM pS-Raf-621 peptide [15] was added to
fibroblast lysates, and anti-KSR immunoprecipitates were
obtained. Addition of this peptide did not block the associa-
tion of Raf with KSR (Fig. 4c); 14-3-3 binding to KSR was,
however, inhibited. These results suggest that the associa-
tion of Raf and KSR is not mediated by 14-3-3. 
In order to analyze the subcellular localization of the
Raf/KSR complex, we fractionated extracts from serum-
starved and serum-stimulated fibroblasts and separately
analyzed anti-Raf immunoprecipitates from the cytosolic
(S100) and membrane (P100) fractions by anti-KSR
immunoblotting. Raf and KSR only formed a complex in
the membrane fraction of serum stimulated cells (Fig. 4d).
Discussion
Members of the recently discovered KSR family of pro-
teins were shown to positively mediate Ras signaling in C.
elegans and Drosophila [17–19], and homologous mam-
malian genes were identified on the basis of sequence
similarity [19]; however, the physiological role of mam-
malian KSR in signal transduction is not well understood.
Here, we have shown that muKSR has biological activity
in Xenopus oocytes; overexpression of muKSR promoted
GVBD, MAP kinase activation, and cdc2 kinase activa-
tion. A measurable response to KSR required co-expres-
sion of 14-3-3. The activity of KSR was blocked by
co-expression of dominant-negative Raf, showing that the
action of KSR requires functional Raf. Our results comple-
ment recent observations from Therrien et al. [27] who
demonstrated that full-length KSR could stimulate
Xenopus oocyte maturation in the presence of oncogenic
Ras, but not alone. Taken together, these observations
suggest that overexpression of KSR stimulates Xenopus
oocyte maturation weakly, such that the effect of KSR can
only be measured in oocytes that have been partially stim-
ulated with a second molecule such as 14-3-3 or activated
Ras. We conclude that KSR is likely to positively mediate
Ras pathway signaling in vertebrate organisms.
Previous analyses of KSR have been largely genetic. Here,
we have begun to investigate the biochemical characteris-
tics of KSR; vertebrate KSR behaved as a 105 kDa protein
that was largely localized to the cytoplasmic compartment
of serum-starved cells and the membrane compartment of
serum-stimulated cells. Invertebrate and vertebrate forms
of KSR contain multiple potential 14-3-3 binding sites,
and we found that invertebrate and vertebrate KSR can
associate with 14-3-3 in yeast nuclei, and that vertebrate
14-3-3 associates with KSR in both the cytosolic and mem-
brane fractions of cell lysates. The observation that both
invertebrate and vertebrate KSR can associate with 14-3-3
protein suggests that this activity of KSR has been widely
conserved and is therefore likely to be functionally signifi-
cant. While our data do not conclusively establish the
functional significance of the interaction between 14-3-3
and KSR, the oocyte experiments suggest that 14-3-3 may
have a stimulatory effect on KSR activity. In addition, the
ability of 14-3-3 protein to bind to both ceKSR and
muKSR implies that this interaction is a conserved prop-
erty of the entire family of KSR proteins.
Homodimerization was recently proposed as a potential
mechanism for Raf kinase activation [25,26]; when Raf
fusion proteins containing engineered dimerization
domains are induced to dimerize, Raf kinase activity is
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Figure 4
(a) Association of muKSR with Raf in vitro. NIH 3T3 cell lysates were
added to immobilized GST–Raf fusion protein or GST alone and, after
extensive washing, bound proteins were analyzed by immunoblotting
using a polyclonal anti-KSR antibody. (b) Co-immunoprecipitation of
KSR and Raf from NIH 3T3 cells. Protein samples (as described for
Fig. 3a) were analyzed by immunoblotting using a polyclonal anti-Raf
antibody. Arrows indicate the bands that correspond to Raf and to IgG
added during immunoprecipitation. (c) Raf binding to KSR is not
mediated by 14-3-3. Subconfluent NIH 3T3 cells were lysed and, in
some instances, 10 mM or 100 mM pS-Raf-621 peptide (Leu–Pro–
Lys–Ile–Asn–Arg–Ser–Ala–pSer–Glu–Pro–Ser–Leu–His–Arg, in
which pSer is phosphoserine) was incubated with the lysate for 12 h at
4°C before immunoprecipitation. Protein samples (as described for
Fig. 3a) were analyzed by immunoblotting using a polyclonal anti-Raf
antibody. (d) Raf/KSR complex formation in serum-stimulated
membrane fractions. Quiescent (–) and serum-stimulated (+) NIH 3T3
cells were lysed in detergent-free buffer, and the extracts were
separated by high-speed centrifugation to obtain cytosolic (S100) and
membrane (P100) fractions. Immunoprecipitates obtained using a
rabbit polyclonal anti-IgG antisera (control IP) and immunoprecipitates
obtained using a rabbit polyclonal anti-Raf antibody (Raf-1 IP) were
analyzed using a monoclonal anti-KSR antisera.
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markedly stimulated. Several other serine/threonine
kinases, including the TGF-b receptors, are activated by
heterodimerization [24]. Here, we have shown that KSR
could form a complex with Raf and that the Raf/KSR
complex was present only in the membrane compartment
of serum-stimulated cells. In contrast, the interaction
between KSR and 14-3-3 occurred in both the cytoplasmic
and membrane compartments of serum-starved and
serum-stimulated cells. Previous work has similarly
demonstrated that 14-3-3 is constitutively bound to Raf in
both membrane and cytoplasmic compartments [10]. Our
results complement findings of Therrien et al. [27] who
demonstrated that KSR and Raf-1 formed a complex in
Drosophila embryos and in co-transfected 293 cells.
Our results suggest that, in serum-starved cells, KSR is
part of a complex that includes 14-3-3 and is primarily
cytoplasmic; following serum stimulation, KSR translo-
cates to the membrane and forms a complex with Raf.
This raises a new and intriguing question: how is KSR
translocated to the membrane? Although our data do not
answer this question, it seems unlikely that Raf brings
KSR to the membrane because Raf and KSR do not
appear to associate in the cytoplasm. KSR, Raf and 14-3-3
all appear to positively regulate Ras signaling, and addi-
tion of KSR to the Ras/Raf/14-3-3 complex may have
important functional consequences. One possibility is that
the addition of KSR to the complex stabilizes the acti-
vated conformation of Raf. Alternatively, KSR may serve
as a linker molecule that recruits substrates for Raf, rather
like the Ste5 protein which tethers multiple MAP kinase
cascade enzymes in budding yeast [28].
Materials and methods
Antibodies
Goat polyclonal anti-KSR antisera, rabbit anti-Raf antisera, and rabbit
anti-ERK1 antisera were obtained from Santa Cruz Biotech. Agarose-
conjugated p13suc was obtained from Upstate Biotechnology Inc. We
generated a murine monoclonal anti-KSR antibody using a KLH-conju-
gated KSR peptide as an immunogen (Cys–Thr–Gln–Gln–Glu–Ile–
Arg–Thr–Leu–Glu–Ala–Lys–Leu–Val–Lys). The KSR peptide and
other peptides described in this work were synthesized using standard
9-Fluorenylmethyloxycarbonyl (FMOC) chemistry and purified by C18
reverse-phase high pressure liquid chromatography. Their identity was
confirmed by amino-acid analysis as described previously [15]. Splenic
lymphocytes from mice injected with the KSR peptide were fused to
myeloma cells and fusion cell supernatants were tested by ELISA using
the KSR peptide. The pS-Raf-621 peptide (amino-acid sequence
Leu–Pro–Lys–Ile–Asn–Arg–Ser–Ala–pSer–Glu–Pro–Ser–Leu–His–Arg,
in which pSer is phosphoserine) was generated and purified as
described previously [15].
Yeast two-hybrid assays
The C. elegans ksr-1 cDNA [17], predicted to encode amino acids
1–771, was inserted into the pGAD plasmid as an in-frame fusion with
the transactivation domain of GAL4 (residues 768–881) [12]. The
muKSR cDNA [19], predicted to encode amino acids 1–874, was
inserted into the pAS1 plasmid as an in-frame fusion with the DNA-
binding domain of GAL4 (residues 1–147) [12]. The human 14-3-3 z
cDNA was inserted into both pGAD and pAS1 as described previously
[12]. Yeast strain Y190 was co-transfected with pGAD-derived and
pAS1-derived plasmids and yeast were plated on media lacking
leucine and tryptophan. The b-galactosidase activity of co-trans-
fected cells was assessed using Xgal as a substrate as described
previously [12].
Protein analysis
NIH 3T3 cells and Xenopus oocytes were lysed using NP40 lysis
buffer (0.5% NP40, 137 mM NaCl, 50 mM NaF, 5 mM EDTA, 10 mM
Tris pH 7.5, 2 mM phenylmethylsulfonyl fluoride, 25 mM leupeptin,
0.2 U ml–1 aprotinin). Lysates were cleared by low-speed centrifugation
and stored at –80°C [20]. For western blot experiments, proteins were
separated by SDS–polyacrylamide gel electrophoresis (SDS–PAGE)
and electrophoretically transferred to nitrocellulose filters. Filters were
blocked with 5% nonfat dried milk and 1% bovine serum albumin in
TBST (10 mM Tris pH 7.5, 150 mM NaCl, 0.1% Tween 20). After incu-
bation in primary antibody, bound antibody was visualized with alkaline
phosphatase or horseradish-peroxidase-coupled secondary antibody
and color-developing agents (Promega) or chemiluminescence-devel-
oping agents (ECL, Amersham). 
For subcellular fractionation experiments, quiescent and serum-stimu-
lated NIH 3T3 cells were lysed in detergent-free lysis buffer (137 mM
NaCl, 50 mM NaF, 5 mM EDTA, 10 mM Tris pH 7.5, 2 mM phenyl-
methylsulfonyl fluoride, 25 mM leupeptin, 0.2 U ml–1 aprotinin), pre-
cleared by low-speed centrifugation (12 000 g for 5 min), and then
separated by centrifugation at 100 000 g for 1 h. Supernatants (S100
fraction) were removed and pellets (P100 fraction) were resuspended
in an equal volume of lysis buffer with 1% Triton X-100 [2,3]. 
For binding assays in vitro, cell lysates were added to immobilized
recombinant GST fusion proteins. The entire coding region of the
human Raf cDNA was subcloned into the bacterial expression vector
pGEX-4T-3 (Pharmacia) and purified GST–Raf fusion protein was
obtained using glutathione–agarose as described previously [15].
NIH 3T3 cell lysates were incubated with immobilized GST–Raf or
GST protein at 4°C for 1 h. Immobilized proteins were washed exten-
sively with lysis buffer containing added NaCl (final concentration 1 M).
Gel sample buffer was added, and boiled samples were separated by
SDS–PAGE, transferred to nitrocellulose membranes, and analyzed by
immunoblotting.
For co-immunoprecipitation assays, protein-A-agarose or protein-G-
agarose (Santa Cruz Biotech) was used to immobilize antibody-bound
proteins. Immunoprecipitates were washed with lysis buffer containing
added NaCl (final concentration 1 M), and analyzed by SDS–PAGE as
above. 
Xenopus oocyte microinjection
Purified plasmid DNA (pSP64T) containing inserts encoding muKSR,
human14-3-3 z, human wild-type Raf, or human Lys375→Met mutated
dominant-negative Raf (NAF) was linearized and used for transcription
in vitro [20]. RNA transcribed in vitro (10–20 nl), at a concentration of
1 mg ml–1, was injected into each oocyte. Some oocytes were stimu-
lated with 8.25 mg ml–1 insulin. 
Mature female frogs were used to obtain Stage VI fully grown immature
oocytes as described previously [20]. Oocytes were maintained in 1×
modified Barth’s solution with HEPES, 1 mg ml–1 Ficoll 400, 1 mg ml–1
bovine serum albumin, and added antibiotics [20]. Injected oocytes
were incubated at 19°C. 
GVBD was assessed by looking for the presence of a broad white spot
on the animal pole of the oocyte. Histone kinase assays were per-
formed using p13suc beads to purify cdc2 from oocyte lysates [12].
After a 1 h incubation at 4°C, immobilized p13 was washed 3 times in
NP40 lysis buffer containing added NaCl (final concentration 1 M).
Kinase reactions were performed in vitro using kinase buffer (20 mM
HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 100 mM ATP), and added
Histone H1 and [32P]ATP. Kinase reactions were terminated after
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15 min by the addition of gel sample buffer. Reaction mixtures were
analyzed by SDS–PAGE followed by autoradiography. 
MAP kinase assays were performed using a polyclonal agarose-conju-
gated anti-MAP-kinase antisera (Santa Cruz Biotech) to purify MAP
kinase from oocyte lysates. After a 1 h incubation at 4°C, anti-MAP-
kinase immunoprecipitates were washed 3 times in NP40 lysis buffer
containing added NaCl (final concentration 1 M). Kinase reactions
were performed in vitro using kinase buffer (20 mM HEPES pH 7.5,
10 mM MgCl2, 1 mM DTT, 100 mM ATP), and added myelin basic
protein (Sigma) and [32P]ATP [20]. Kinase reactions were terminated
after 20 min by the addition of gel sample buffer. Reaction mixtures
were analyzed by SDS–PAGE. Bands that corresponded to myelin
basic protein were isolated and analyzed by scintigraphy.
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